Fundies.
English

iBio, Inc.

EDGAR
IBIO Current report (8-K) · filed 2026-10-19

Annual consolidated revenue for 2026: about Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 100K, using the latest reported figures. The previous period, 2025, was about Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 400K.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

0 Unit_Standard_USD_5XngsiiRP0-CC9IAYP0U7Q

2026 Q2 · Unit_Standard_USD_5XngsiiRP0-CC9IAYP0U7Q

Exact inputs and evidence
  • Revenue: 0 Unit_Standard_USD_5XngsiiRP0-CC9IAYP0U7Q Source
Cash and cash equivalents
56.4 million Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA Source
Exact value

56395000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA

Long-term debt including current maturities
Not available
Shares outstanding
55.7 million Unit_Standard_shares_aSDoMiwl5UKxwmgxN-KB4w Source
Exact value

55698561 Unit_Standard_shares_aSDoMiwl5UKxwmgxN-KB4w

Reported share-count change

187.86% · 36.3 million Unit_Standard_shares_aSDoMiwl5UKxwmgxN-KB4w

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 19349201 Unit_Standard_shares_aSDoMiwl5UKxwmgxN-KB4w · 2025-06-30· Source
  • 55698561 Unit_Standard_shares_aSDoMiwl5UKxwmgxN-KB4w · 2026-06-30· Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-19.

Financial data available through: 2026-06-30.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2026-06-30
  • Operating income: 2 of 11 periods available· newest 2026-06-30
  • Net income: 2 of 11 periods available· newest 2026-06-30
  • Operating cash flow: 2 of 11 periods available· newest 2026-06-30
  • Capital expenditure: 2 of 11 periods available· newest 2026-06-30
  • Total assets: 2 of 11 periods available· newest 2026-06-30
  • Total liabilities: 2 of 11 periods available· newest 2026-06-30
  • Current assets: 2 of 11 periods available· newest 2026-06-30
  • Current liabilities: 2 of 11 periods available· newest 2026-06-30
  • Cash and cash equivalents: 2 of 11 periods available· newest 2026-06-30
  • long term debt: No compatible figures in this window
  • Shares outstanding: 2 of 11 periods available· newest 2026-06-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -75%

    Prior period

    Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 400,000

    –

    Current period

    Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 100,000

    –

    Exact inputs and evidence

    100000 − 400000 = -300000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA

    400000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA · 2024-07-01 – 2025-06-30

    Inspect prior input Prior source

    100000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA · 2025-07-01 – 2026-06-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    −Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 14.62 million

    Prior period

    −Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 18.38 million

    –

    Current period

    −Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 33 million

    –

    Exact inputs and evidence

    -33000000 − -18377000 = -14623000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA

    -18377000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA · 2024-07-01 – 2025-06-30

    Inspect prior input Prior source

    -33000000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA · 2025-07-01 – 2026-06-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 7.9 million

    Prior period

    −Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 15.3 million

    –

    Current period

    −Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 23.2 million

    –

    Exact inputs and evidence

    -23200000 − -15300000 = -7900000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA

    -15300000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA · 2024-07-01 – 2025-06-30

    Inspect prior input Prior source

    -23200000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA · 2025-07-01 – 2026-06-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +3,512.5%

    Prior period

    Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 16,000

    –

    Current period

    Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 578,000

    –

    Exact inputs and evidence

    578000 − 16000 = 562000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA

    16000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA · 2024-07-01 – 2025-06-30

    Inspect prior input Prior source

    578000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA · 2025-07-01 – 2026-06-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2026 2025-07-01 – 2026-06-30

  • Revenue Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 100,000 100% of revenue
  • Operating costs Derived Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 35.24 million 35,241% of revenue
  • Operating income −Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 35.14 million −35,141% of revenue
  • Tax, interest and other Derived −Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 2.14 million −2,141% of revenue
  • Net income −Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 33 million −33,000% of revenue

Cash

  • Operating cash flow −Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 23.2 million −23,200% of revenue
  • Capital expenditure Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 578,000 578% of revenue
  • Free cash flow Derived −Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 23.78 million −23,778% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2025 Operating loss: operating costs were 4,751% of revenue.
  • 2026 Operating loss: operating costs were 35,241% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2025 2024-07-01 – 2025-06-30400000 19002000 Derived -18602000 -225000 Derived -18377000 -15316000 Derived
Source
2026 2025-07-01 – 2026-06-30100000 35241000 Derived -35141000 -2141000 Derived -33000000 -23778000 Derived
Source

Amounts are exact, in Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 100K 2026
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.432.0K324.0K216.0K108.0K0.020252026
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA)Source evidence
2025Revenue400000
2026Revenue100000

Revenue growth

Change in revenue from the same financial period one year earlier.

-75% 2026
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.6%-16%-38%-59%-81%20252026
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2025Year over yearNo prior comparable period
2026Year over year-75%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -35,141% 2026
Net margin -33,000% 2026
Free cash flow margin -23,778% 2026
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2,811%-7,380%-17,571%-27,761%-37,952%20252026
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2025Operating margin-4,650.5%
2026Operating margin-35,141%
2025Net margin-4,594.3%
2026Net margin-33,000%
2025Free cash flow margin-3,829%
2026Free cash flow margin-23,778%

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA -23.2M 2026
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.9M-4.9M-11.6M-18.3M-25.1M20252026
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA)Source evidence
2025Operating cash flow-15300000
2026Operating cash flow-23200000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA -23.8M 2026
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.9M-5.0M-11.9M-18.8M-25.7M20252026
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA)Source evidence
2025Free cash flow-15316000
2026Free cash flow-23778000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

13.5% 2026
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.38.7%29.0%19.3%9.7%0.0%20252026
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2025Liabilities / assets35.8%
2026Liabilities / assets13.5%

Current assets to current liabilities

Current assets divided by current liabilities.

7.85× 2026
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.8.48×6.36×4.24×2.12×0.00×20252026
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2025Current assets / current liabilities1.59×
2026Current assets / current liabilities7.85×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2025 2024-07-01 – 2025-06-30
−Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 18.38 million
Exact value

Exact value: -18377000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA

2024-07-01 – 2025-06-30: -18377000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 15.3 million
Exact value

Exact value: -15300000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA

2024-07-01 – 2025-06-30: -15300000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 16,000
Exact value

Exact value: 16000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA

2024-07-01 – 2025-06-30: 16000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 15.32 million
Calculation and evidence

-15300000 − 16000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA

Exact free cash flow: -15316000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2026 2025-07-01 – 2026-06-30
−Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 33 million
Exact value

Exact value: -33000000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA

2025-07-01 – 2026-06-30: -33000000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 23.2 million
Exact value

Exact value: -23200000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA

2025-07-01 – 2026-06-30: -23200000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 578,000
Exact value

Exact value: 578000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA

2025-07-01 – 2026-06-30: 578000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA 23.78 million
Calculation and evidence

-23200000 − 578000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA

Exact free cash flow: -23778000 Unit_Standard_USD_6YYoMGJvMk6U0BuvpykPFA

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

111 filings · 6,352 latest values · 6,352 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001420720, 1420720, IBIO, edgar:1420720

Also known as InB:Biotechnologies, Inc., iBio, Inc., iBio, Inc. , iBio, Inc., iBioPharma, Inc.